EZH2 and non-small cell lung carcinoma: Nevertheless, BM-MSCs-exo which carried miR-30b-5p showed potential in decreasing EZH2 expression, inhibiting tumor cell proliferation, migration, and invasion, and inducing apoptosis, thereby restraining the development of tumors in a non-small-cell lung cancer model [34].